Literature DB >> 11456364

Mechanisms of antifungal agent resistance.

Y L Yang1, H J Lo.   

Abstract

During the past decade, yeast infections have had an important role in nosocomial infections due to alterations in the immune status of patients. Coincidentally with the increased usage of antifungal agents, the number of reports of drug resistance has increased, which highlights the need for understanding the molecular mechanisms of antifungal agent resistance. This review describes the mechanisms of action of antifungal agents, cellular factors contributing to drug resistance, the known molecular mechanisms of drug resistance, and proposed but unproved molecular mechanisms of drug resistance. This review also proposes possible strategies for preventing drug resistance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11456364

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  18 in total

1.  Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus.

Authors:  Paul Bowyer; Juan Mosquera; Michael Anderson; Mike Birch; Michael Bromley; David W Denning
Journal:  FEMS Microbiol Lett       Date:  2012-05-21       Impact factor: 2.742

2.  A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.

Authors:  Shaoji Cheng; Cornelius J Clancy; Katherine T Nguyen; William Clapp; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

3.  Characterization of Candida species from different populations in Taiwan.

Authors:  Yun-Liang Yang; Li-Yun Hsieh; An-Huei Wang; Hsiu-Jung Lo
Journal:  Mycopathologia       Date:  2011-03-03       Impact factor: 2.574

4.  Loss of heterozygosity of FCY2 leading to the development of flucytosine resistance in Candida tropicalis.

Authors:  Yen-Ning Chen; Hsiu-Jung Lo; Chia-Chen Wu; Hui-Ching Ko; Te-Pin Chang; Yun-Liang Yang
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

5.  CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1.

Authors:  Chia-Geun Chen; Yun-Liang Yang; Hsin-I Shih; Chia-Li Su; Hsiu-Jung Lo
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients.

Authors:  S Y Li; Y L Yang; K W Chen; H H Cheng; C S Chiou; T H Wang; T L Lauderdale; C C Hung; H J Lo
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

Review 7.  In search of the holy grail of antifungal therapy.

Authors:  Stanley W Chapman; Donna C Sullivan; John D Cleary
Journal:  Trans Am Clin Climatol Assoc       Date:  2008

8.  Rondonin an antifungal peptide from spider (Acanthoscurria rondoniae) haemolymph.

Authors:  K C T Riciluca; R S R Sayegh; R L Melo; P I Silva
Journal:  Results Immunol       Date:  2012-04-02

9.  Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole.

Authors:  Yun-Liang Yang; Chih-Chao Lin; Te-Pin Chang; Tsai-Ling Lauderdale; Hui-Ting Chen; Ching-Fu Lee; Chih-Wen Hsieh; Pei-Chen Chen; Hsiu-Jung Lo
Journal:  PLoS One       Date:  2012-04-05       Impact factor: 3.240

10.  Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients.

Authors:  Yun-Liang Yang; Ming-Fang Cheng; Ya-Wen Chang; Tzuu-Guang Young; Hsin Chi; Sai Cheong Lee; Bruno Man-Hon Cheung; Fan-Chen Tseng; Tun-Chieh Chen; Yu-Huai Ho; Zhi-Yuan Shi; Chung-Huang Hubert Chan; Ju-Yu Lin; Hsiu-Jung Lo
Journal:  J Negat Results Biomed       Date:  2008-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.